Expression of LIGHT in a fibrosarcoma cell line resulted in upregulation of CCL21 and MAdCAM-1 on tumor vasculature, facilitating recruitment of vast numbers of naive CD8+ T lymphocytes, which appeared to then be sufficiently activated in situ to facilitate rejection of established tumors (91). The gene discussed is CCL21; the disease is neoplasm.